Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Running, not enrolling · Not applicable

Conditions studied: Heart Failure

In brief

The objective of the RELIEVE-HF study is to provide reasonable assurance of safety and effectiveness of the V-Wave Interatrial Shunt System by improving meaningful clinical outcomes in patients with New York Heart Association (NYHA) functional Class II, Class III, or ambulatory Class IV heart failure (HF), irrespective of left ventricular ejection fraction, who at baseline are treated with guideline-directed drug and device therapies.

Key facts

Study ID
NCT03499236
Run by
V-Wave Ltd
People needed
605
Starts
2018-09-19
Expected to finish
2027-10-31
Last updated by the study team
2025-08-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.